Deep-Vein Thrombosis Frequently Asked Questions (FAQs)

Many people have suffered from deep-vein thrombosis, or DVT, without even knowing its name. So it’s not surprising that patients and healthcare professionals alike want to know more about this condition. Below are some answers designed to broaden or refresh your knowledge about DVT.

Deep-vein thrombosis (DVT) is a common but serious medical condition that occurs in approximately two million Americans each year.1 DVT occurs when a blood clot (thrombus) forms in one of the large veins, usually in the lower limbs, leading to either partially or completely blocked circulation. The condition may result in health complications, such as a pulmonary embolism (PE) and even death if not diagnosed and treated effectively.

A pulmonary embolism (PE) occurs when a blood clot is lodged in the artery that carries blood from the heart to the lungs (pulmonary artery), causing a severe dysfunction in respiratory function.  PEs often come from the deep leg veins and travel to the lungs through blood circulation. Symptoms include sudden shortness of breath (that becomes worse with breathing), and rapid heart and respiratory rates.

Blood clots form to help heal the body after an injury.  For example, clots are what stop the bleeding in a cut or wound.  In most situations, blood clots are a natural part of the healing process.  They enable the injured tissue to begin to repair itself without excessive blood loss.  In the case of DVT, however, the body signals the clotting process to occur unnecessarily at the wrong time and in the wrong place.12

  • VenaPro will run for about 500 hours
  • Product is carries a warranty for 500 hours or 60 days 

Blood clots can occur anywhere in the body. However, DVT occurs only in deep veins. Most often it occurs in the legs, thighs, and pelvis.

  • Congestive heart failure or respiratory failure
  • Restricted mobility
  • Cancer
  • Obesity
  • Age over 40 years
  • Recent surgery
  • Smoking
  • Prior or family history of venous thromboembolism (VTE)

 

*This is a partial list of risk factors

DVT occurs most commonly in adults over 40, but anyone at risk can develop it.

Symptoms of DVT may include pain, swelling, tenderness, discoloration or redness of the affected area, and skin that is warm to the touch. However, as many as half of all DVT episodes produce minimal symptoms or are completely “silent.” Because a number of other conditions — including muscle strains, skin infections, and phlebitis (inflammation of veins) — display symptoms similar to those of DVT, the condition may be difficult to diagnose without specific tests.14 Advise your patients to see you immediately if they have any of the symptoms listed above.

DVT occurs in about 2 million Americans each year, and up to 600,000 people are hospitalized in the United States each year for DVT and its primary complication, PE.1 An estimated 300,000 first-time cases of DVT occur in the United States every year.9 More people die in the United States from PE than from breast cancer and AIDS combined.1

If you are at risk for DVT, or have experienced a prior DVT or PE, you can still make long-distance trips, as long as you take some simple precautions.  Recommend that before patients leave for a long trip, they practice calf and leg exercises they can do while sitting, and that during their trip; they stretch their legs as much as possible.  They may also want to wear compression stockings to help the circulation of blood in the legs.  Remind them to stay hydrated; dehydration can increase the concentration of clotting factors in the blood.  If patients will be traveling for more than four hours, you may consider recommending treatment with an anticoagulant, or “blood thinner,” before they leave.15

In the diagnosis of DVT, you will take into account the patient’s specific risk factors, the patient’s symptoms, and the results of objective tests, such as some method of imaging the clot. Possible tests include: duplex ultrasound, venography and magnetic resonance imaging (MRI), and the d-Dimer test.  Please see the examination section of the toolkit to get more detailed information on the tests used to diagnose DVT.16

How is DVT/PE treated?

  1. The initial treatment of both DVT and PE is anticoagulants, also known as “blood thinners.” These medications do not actually thin blood; instead, they block the action of various clotting factors and prevent blood clots from growing in order to allow the body’s own nature processes to destroy clots over time.

DVT and PE usually resolve successfully, allowing patients to return to their previous activities. Advise your patient to listen to his or her body while exercising, but recognize that immobility is an important risk factor for DVT and PE, so activity is important in helping to prevent future blood clots.

A patient’s chance of having another DVT or PE depends on the specifics surrounding his or her first DVT or PE.  If the blood clot occurred as a result of surgery or trauma, and the risk factor was considered temporary, then the risk of having another DVT or PE may be very low.  If the blood clot occurred spontaneously, without any risk factors being present, the risk of another clot is 30 percent over the next 10 years.17

Most healthy people may be at low risk of developing DVT, but it can happen. Be aware of the risk factors and that over time your risk factors can change.  Assess your risk on a regular basis, and if you observe anything suspicious, speak with your healthcare provider right away.

Yes. Both oral contraceptives and hormone replacement therapy may increase the tendency of the blood to clot.  Keep in mind, however, that millions of women have taken oral contraceptives without encountering this problem; the affected population is relatively small.

Obesity is a risk factor for both cardiovascular disease and DVT.  It makes it more difficult for blood to circulate throughout the body and often results in low activity levels, both of which can increase your risk of DVT.

In patients with an easily identified and reversible cause of a deep vein thrombosis, 4 to 6 weeks of therapy may be sufficient.  For cases in which the risk of developing new thromboses remains high (such as in patients with certain cancers or genetic abnormalities), therapy may need to be continued for months to years. Some patients remain on oral medication for life.

A Commitment to Excellence

VenaPro Increases patient safety by decreasing the incidence of deep vein thrombosis (DVT) and related pulmonary embolism (PE), which together affect more than two million Americans every year.

Raising the Standard

VenaPro is designed for optimal patient comfort and compliance. When portability is the priority your solution is VenaPro, designed for optimal patient comfort and compliance.

Will My Patients Use It

Compared to non-miniaturized, portable, sequential, pneumatic compression devices on the ability to prevent post-operative DVT Found higher compliance rates with the mobile portable device (78%) versus the non-mobile device (59%)

Call Us
OR

Place an Order and Experience the Latest in DVT Prevention

  1. Gerotziafas GT, Samama MM. Prophylaxis of venous thromboembolism medical patients. CurrOpin PulmMed. 2004; 10:356-365.
  2. About.com. How the Blood Clots; How to Prevent Abnormal Clotting. Available at http://heartdisease.about.com/cs/heartattacks/a/clotting_3.htm (Accessed September 15, 2009).
  3. Geerts WH, Pineo GF, Heit JA et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest.2004; 126(suppl): 338S-400S.
  4. Vascular Disease Foundation. Frequently Asked Questions. Available at http://www.vdf.org/diseaseinfo/dvt/faqs.php [Accessed September 15,2009].
  5. Clot Care Online Resource. What is the d-Dimer test? Available at: http://www.clotcare.com/clotcare/faq_ddimertest.aspx [Accessed September 15,2009].
  6. Heit JA. Venous thromboembolism epidemiology. Semin Thromb Hemost. 2002;28(suppl 2):3-13.